Medication-Assisted Treatment (MAT)

Medication-assisted treatment (MAT) is the use of medications for the treatment of substance use disorders. MAT is primarily used for the treatment of addiction to opioids such as heroin and prescription pain relievers that contain opiates.

Buprenorphine is a medication approved by the Food and Drug Administration (FDA) to treat Opioid Use Disorder (OUD) as a medication-assisted treatment (MAT). As with all medications used in MAT, buprenorphine should be prescribed as part of a comprehensive treatment plan that includes counseling and other behavioral therapies to provide patients with a whole-person approach.

MEDICAID: The American Society of Addiction Medicine (ASAM) Criteria are used to determine substance abuse treatment placement/admission and/or continued stay needs. The service is based on a level of care determination using the six assessment dimensions of the current ASAM Criteria:

  • Withdrawal potential
  • Medical conditions and complications
  • Emotional, behavioral or cognitive conditions and complications
  • Readiness to change
  • Relapse, continued use or continued problem potential
  • Recover/living environment